Brasil, o de prostata ainda atinge mais os homens que o de mama afeta as mulheres, de acordo com o Inca. Apesar de a prostata ser o problema mais frequente nos homens, com 60.180 novos casos previstos para este ano, o cancer de pulmao mata mais.Casos previstos de cancer em mulheres no Brasil*Mama 52.680Colo do utero 17.540Colon e reto 15.960Tireoide 10.590Traqueia, bronquios e pulmoes 10.110Canceres que mais matam mulheres no Brasil**Mama 12.705Traqueia, bronquios e pulmoes 8.190Colon, reto e anus 6.892Estomago 4.768Pancreas 3.769* Estimativas para 2012**Dados de 2010 do SUS______________________________________________________________________________ Trastuzumab will be incorporated into the treatment of the disease made by SUS. Cost per patient in quimioterapira can exceed $ 35,000.The Ministry of health shall publish in the "Diario Oficial da Uniao" next Wednesday (25) Ordinance which provides for the incorporation of the drug Trastuzumab in breast cancer treatments performed by the single health system (SUS). The medicine is already used in the country, but only in the private sector, since it is considered high cost.Will be invested R $ 130 million per year for the acquisition of the drug, which will be made available on the public network health up to 180 days, according to the Ministry.According to the federal Government, the drug is more effective in curing the disease, since it reaches only cancer cells and prevents side effects felt on the application of other remedies. According to the Ministry, Trastuzumab is recommended for 25% of patients diagnosed and decreases in 22% the risk of death of patients.The use of the product on the public network was under discussion for a year in National Commission (Conitec) technologies discussion group, which brings together experts and health authorities. They analyzed the effectiveness of the remedy and its efficiency in the treatment of early breast cancer and advanced.According to the Government, each milligram can cost up to R $ 11.75, depending on the laboratory. According to the oncologist-Samuel Lamb of Lima, Clinical Hospital A.C. Camargo, of Sao Paulo, the cost per patient may exceed $ 35,000.According to him, for example, the first dose of the treatment for an 80 kg person requiring six sessions of chemotherapy would cost up to R $ 7,520 (640 mg). In the other five sessions, the patient would receive 480 mg Trastuzumab, which would total $ 28,100 (R $ 5,620 each application).Risk factorsBreast cancer is the leading cause of female deaths. Affect hundred of 100 thousand women per year in developed countries. Annually, more than 1.3 million new cases are diagnosed, 53 thousand of them in France.In Brazil, is the first cause of death in women by tumor in the country. Among the deaths by diseases in general female literacy, loses only for cardiovascular problems such as heart attack and stroke (CVA).The risk factors for this type of tumor are varied. They include genetic mutations, a first pregnancy low late parity, hormonal replacement therapies in patients predisposed, lifestyle habits, and environmental causes and professionals not yet fully identified.The National Cancer Institute (Inca) estimates, for 2012, a total of 52,680 new cases of breast cancer among women. By region,